Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) EVP Nathan G. Brower sold 9,996 shares of the company's stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $16.54, for a total value of $165,333.84. Following the sale, the executive vice president owned 48,277 shares of the company's stock, valued at approximately $798,501.58. This trade represents a 17.15% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Nature's Sunshine Products Price Performance
Shares of NATR stock traded down $0.32 during trading on Wednesday, reaching $16.49. The company had a trading volume of 89,329 shares, compared to its average volume of 96,188. The firm's 50 day simple moving average is $15.27 and its two-hundred day simple moving average is $14.09. Nature's Sunshine Products, Inc. has a one year low of $11.01 and a one year high of $18.06. The company has a market capitalization of $290.88 million, a PE ratio of 22.28 and a beta of 1.14.
Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $0.35 EPS for the quarter, beating the consensus estimate of $0.16 by $0.19. The company had revenue of $114.75 million for the quarter, compared to the consensus estimate of $113.10 million. Nature's Sunshine Products had a return on equity of 10.19% and a net margin of 3.06%. Nature's Sunshine Products has set its FY 2025 guidance at EPS.
Analysts Set New Price Targets
Several equities research analysts have recently issued reports on NATR shares. Canaccord Genuity Group raised their price target on Nature's Sunshine Products from $21.00 to $22.00 and gave the company a "buy" rating in a research report on Friday, August 1st. DA Davidson restated a "buy" rating and set a $19.00 target price on shares of Nature's Sunshine Products in a research note on Tuesday, June 3rd. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has an average rating of "Buy" and a consensus price target of $19.67.
Check Out Our Latest Research Report on NATR
Institutional Trading of Nature's Sunshine Products
Institutional investors have recently made changes to their positions in the business. Manatuck Hill Partners LLC bought a new stake in Nature's Sunshine Products in the second quarter valued at about $1,923,000. Bank of America Corp DE grew its stake in shares of Nature's Sunshine Products by 71.1% in the 2nd quarter. Bank of America Corp DE now owns 43,937 shares of the company's stock valued at $650,000 after purchasing an additional 18,259 shares during the period. Ameriprise Financial Inc. raised its holdings in shares of Nature's Sunshine Products by 1.4% in the 2nd quarter. Ameriprise Financial Inc. now owns 54,008 shares of the company's stock worth $799,000 after buying an additional 753 shares in the last quarter. AWM Investment Company Inc. bought a new position in shares of Nature's Sunshine Products during the 2nd quarter worth approximately $5,176,000. Finally, Jane Street Group LLC lifted its position in shares of Nature's Sunshine Products by 18.4% during the 2nd quarter. Jane Street Group LLC now owns 16,369 shares of the company's stock worth $242,000 after buying an additional 2,538 shares during the period. 79.40% of the stock is currently owned by institutional investors and hedge funds.
About Nature's Sunshine Products
(
Get Free Report)
Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Featured Articles
Before you consider Nature's Sunshine Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nature's Sunshine Products wasn't on the list.
While Nature's Sunshine Products currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
